About Curever
Curever is a Healthcare company based in Mumbai (India). Pharmaceutical company focusing on therapy areas like anti-infective and cardio in India. The company has 14 employees. Its Indian entity Curever Pharma Private Limited reported revenue of ₹56.8 Lakh. Curever offers products and services including Anti-Infective Medicines and Cardio Medicines. Its focus areas include Pharmaceuticals, Anti-Infective Therapy, Infection Treatments and Nutraceuticals.
Company details
Curever is aimed at serving as a health partner in the development of a Healthy India, where the population is supported to be healthy in body and mind. A variety of world-class quality medicines is made available at nearby pharmacies to introduce the latest medical technologies for citizen benefits. It is ensured that health improvements are facilitated across categories such as anti-infective, skin care, and digestive therapies, with an emphasis on doctor consultations. Approximately 6 of revenue is managed from gastrointestinal medicines, while efforts are directed towards combating infections and other conditions. Overall, Curevers offerings are designed to enhance quality of life through accessible healthcare solutions.
- Headquarters Mumbai, India
- Employees 14
- SectorsHealthcare
- Email••••••••
- Social Facebook Instagram
- Legal Name Curever Pharma Private Limited
- Date of Incorporation 19 Jan, 2021
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹56.8 Lakh
FY 2025 · -79% YoY
- Net Profit₹41.67 Cr
FY 2025 · 7336% margin
- EBITDA₹45.54 Cr
FY 2025 · 8018% margin
- Employee Count14
Associated legal entities of Curever
Curever operates through Curever Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Curever Pharma Private Limited CIN U24230MH2021PTC353725 | Active | 19 Jan 2021 | Mumbai, Maharashtra | ₹0.6 Cr | 14 | 2 | View details |
Products & Services of Curever
Curever offers a comprehensive portfolio of products and services, including Anti-Infective Medicines and Cardio Medicines.
Medicines are provided to combat various types of infections across different therapy areas.
Products are offered for the treatment of cardiovascular diseases, which are recognized as a leading cause of death.
Board of directors of Curever Pharma Private Limited (Curever)
Curever Pharma Private Limited is the primary company behind Curever. The board of Curever Pharma Private Limited currently have 2 directors; the longest-serving is Kaushik Balakrishnan Natesan, appointed in 2021. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kaushik Balakrishnan Natesan DIN 08299186 | Director | 19 Jan 2021 | 5 yrs 9 mo | Curever Pharma Private Limited |
| Prashant Srivastava DIN 09755730 | Director | 04 Oct 2022 | 4 yrs | Curever Pharma Private Limited |
Financials of Curever
Figures of Curever Pharma Private Limited, the primary company behind Curever, for FY 2025. Revenue was ₹56.8 Lakh (-79% year on year). Net profit was ₹41.67 Cr (7336% margin). EBITDA was ₹45.54 Cr (8018% margin). Revenue has grown at a compounded annual rate of -68% over three years.
- ₹56.8 LakhRevenue · FY 2025 · -79% YoY
- ₹41.67 CrNet profit · 7336% margin
- ₹45.54 CrEBITDA · 8018% margin
- ₹1 LakhPaid-up capital
- 14Employees (provident fund records)
- -68%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Curever Pharma Private Limited are on its company page.
Detailed financial statements for Curever
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Curever
Curever is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Curever has 14 employees.
The primary company behind Curever, Curever Pharma Private Limited, reported revenue of ₹56.8 Lakh for FY 2025, down 79% year on year.
Curever is aimed at serving as a health partner in the development of a Healthy India, where the population is supported to be healthy in body and mind. A variety of world-class quality medicines is made available at nearby pharmacies to introduce the latest medical technologies for citizen benefits. It is ensured that health improvements are facilitated across categories such as anti-infective, skin care, and digestive therapies, with an emphasis on doctor consultations. Approximately 6 of revenue is managed from gastrointestinal medicines, while efforts are directed towards combating infections and other conditions. Overall, Curevers offerings are designed to enhance quality of life through accessible healthcare solutions.
Curever offers Anti-Infective Medicines and Cardio Medicines.
Curever operates through Curever Pharma Private Limited.
The legal entities of Curever currently have 2 directors, including Prashant Srivastava, Kaushik Balakrishnan Natesan.